神经元重于肾脏:急性卒中患者对比剂肾病的系统综述与Meta分析
病例对照研究中CTA/CTP组AKI odds显著低于非增强CT组(OR=0.47,95%CI 0.33-0.68,P<0.01),但调整基线肌酐后差异无统计学意义(OR=0.34,95%CI 0.10-1.21)。CTA/CTP组总体AKI率为3%(95%CI 2%-4%),透析率为0.07%(3/4373),合并与不合并慢性肾脏病者AKI无差异(OR=0.63,95%CI 0.34-1.12)。
要点
- CTA/CTP后急性肾损伤总体发生率低(3%),透析罕见(0.07%)。
- 调整基线肌酐后,CTA/CTP与非增强CT的AKI风险无显著差异。
- 合并慢性肾脏病不增加CTA/CTP相关AKI风险(OR=0.63,95%CI 0.34-1.12)。
核心结论
- 非随机证据提示CTA/CTP不显著增加卒中患者AKI风险,即使已知慢性肾脏病。
主要发现
- 病例对照研究中CTA/CTP组AKI odds显著低于非增强CT组(OR=0.47,95%CI 0.33-0.68,P<0.01)。
- 调整基线肌酐后两组AKI率无差异(OR=0.34,95%CI 0.10-1.21)。
- CTA/CTP组总体AKI率为3%(95%CI 2%-4%)。
- CTA/CTP组总体透析率为0.07%(3/4373)。
- 合并与不合并慢性肾脏病的CTA/CTP患者AKI无差异(OR=0.63,95%CI 0.34-1.12)。
临床怎么用
- 急性缺血性卒中患者行CTA/CTP前无需因担心对比剂肾病而延迟影像检查。
- 已知慢性肾脏病并非CTA/CTP的绝对禁忌,可结合临床个体化评估。
局限性
- 纳入研究均为非随机设计,可能存在选择偏倚和混杂。
- 调整基线肌酐后样本量有限,置信区间较宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Because of the perceived risk of contrast-induced acute kidney injury (AKI), many centers require pre-imaging serum creatinine levels, potentially delaying care. We performed a systematic review and meta-analysis evaluating AKI rates in patients with acute ischemic stroke receiving computed tomographic angiography (CTA) and computed tomographic perfusion (CTP). METHODS: We searched MEDLINE, EMBASE, and the Web of Science through December 2016 for studies reporting on AKI in patients with acute ischemic stroke receiving CTA/CTP. Using a random-effects model, estimates were pooled across studies. Outcomes of interest were (1) the odds of AKI in patients receiving CTA/CTP versus noncontrast computed tomography, (2) overall rate of AKI and hemodialysis in patients with acute ischemic stroke undergoing CTA/CTP, and (3) the odds of CTA/CTP-associated AKI among patients with and without chronic kidney disease. RESULTS: Fourteen studies were included (6 case-control studies and 8 single-arm studies) with 5727 CTA/CTP and 981 noncontrast computed tomography patients. In case-control studies, AKI was significantly lower among CTA/CTP patients compared with noncontrast computed tomography patients (odds ratio=0.47; 95% confidence interval=0.33-0.68; P<0.01). Adjusting for baseline creatinine, there was no difference in AKI rates between groups (odds ratio=0.34; 95% confidence interval=0.10-1.21). The overall rate of AKI in CTA/CTP patients was 3% (95% confidence interval=2%-4%). The overall rate of hemodialysis in the CTA/CTP group was 0.07% (3 of 4373). There was no difference in AKI among CTA/CTP patients with and without chronic kidney disease (odds ratio=0.63; 95% confidence interval=0.34-1.12). CONCLUSIONS: Nonrandomized evidence suggests that CTA/CTP are not associated with statistically significant increase in risk of AKI in patients with stroke, even those with known chronic kidney disease.
引用
- Brinjikji W, Demchuk AM, Murad MH, et al. Neurons Over Nephrons: Systematic Review and Meta-Analysis of Contrast-Induced Nephropathy in Patients With Acute Stroke. Stroke. 2017. PMID: 28583996. doi:10.1161/STROKEAHA.117.016771
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。